231 related articles for article (PubMed ID: 26806835)
21. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
22. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells.
Kobayashi T; Uehara S; Ikeda T; Itadani H; Kotani H
Kidney Int; 2003 Nov; 64(5):1632-42. PubMed ID: 14531794
[TBL] [Abstract][Full Text] [Related]
24. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
25. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression.
Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX
Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086
[TBL] [Abstract][Full Text] [Related]
26. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.
Siddiqi FS; Majumder S; Thai K; Abdalla M; Hu P; Advani SL; White KE; Bowskill BB; Guarna G; Dos Santos CC; Connelly KA; Advani A
J Am Soc Nephrol; 2016 Jul; 27(7):2021-34. PubMed ID: 26534922
[TBL] [Abstract][Full Text] [Related]
27. Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice.
Shen M; Bai D; Liu B; Lu X; Hou R; Zeng C; Li N; Fu Z; Li C; Tao L; Wang H; Yin T
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3735-3745. PubMed ID: 30261287
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide-dependent suppression of thioredoxin-interacting protein expression enhances thioredoxin activity.
Schulze PC; Liu H; Choe E; Yoshioka J; Shalev A; Bloch KD; Lee RT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2666-72. PubMed ID: 17023680
[TBL] [Abstract][Full Text] [Related]
29. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Lab Invest; 2014 Mar; 94(3):309-20. PubMed ID: 24492284
[TBL] [Abstract][Full Text] [Related]
30. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein.
He X; Ma Q
Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells.
Baldan F; Mio C; Lavarone E; Di Loreto C; Puglisi F; Damante G; Puppin C
Oncol Rep; 2015 May; 33(5):2199-206. PubMed ID: 25812606
[TBL] [Abstract][Full Text] [Related]
32. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.
Huang C; Zhang Y; Kelly DJ; Tan CY; Gill A; Cheng D; Braet F; Park JS; Sue CM; Pollock CA; Chen XM
Sci Rep; 2016 Jul; 6():29196. PubMed ID: 27381856
[TBL] [Abstract][Full Text] [Related]
33. p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.
Ren Y; Shi Y; Wang Y; Li Y; Wu S; Li H; Zhang Y; Duan H
FEBS Lett; 2010 Aug; 584(15):3480-5. PubMed ID: 20624390
[TBL] [Abstract][Full Text] [Related]
34. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204.
Xu G; Chen J; Jing G; Shalev A
Nat Med; 2013 Sep; 19(9):1141-6. PubMed ID: 23975026
[TBL] [Abstract][Full Text] [Related]
35. LncRNA SNHG15 relieves hyperglycemia-induced endothelial dysfunction via increased ubiquitination of thioredoxin-interacting protein.
Zhu QQ; Lai MC; Chen TC; Wang X; Tian L; Li DL; Wu ZH; Wang XH; He YY; He YY; Shang T; Xiang YL; Zhang HK
Lab Invest; 2021 Sep; 101(9):1142-1152. PubMed ID: 34103662
[TBL] [Abstract][Full Text] [Related]
36. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
Turturro F; Von Burton G; Friday E
Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
[TBL] [Abstract][Full Text] [Related]
37. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice.
Jo SH; Kim MY; Park JM; Kim TH; Ahn YH
Diabetologia; 2013 Dec; 56(12):2723-32. PubMed ID: 24037087
[TBL] [Abstract][Full Text] [Related]
38. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
39. Chronic advanced-glycation end products treatment induces TXNIP expression and epigenetic changes in glomerular podocytes in vivo and in vitro.
Thieme K; Pereira BMV; da Silva KS; Fabre NT; Catanozi S; Passarelli M; Correa-Giannella ML
Life Sci; 2021 Apr; 270():118997. PubMed ID: 33453249
[TBL] [Abstract][Full Text] [Related]
40. Cognitive Decline, Cerebral-Spleen Tryptophan Metabolism, Oxidative Stress, Cytokine Production, and Regulation of the Txnip Gene in a Triple Transgenic Mouse Model of Alzheimer Disease.
Fertan E; Rodrigues GJ; Wheeler RV; Goguen D; Wong AA; James H; Stadnyk A; Brown RE; Weaver ICG
Am J Pathol; 2019 Jul; 189(7):1435-1450. PubMed ID: 30980800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
